Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The goal of this clinical trial is to learn about the benefit of IVIG in donor-derived infections and the potential immunomodulatory effect on transplanted organs. The main questions it aims to answer are: 1. How effective IVIG is in preventing donor-derived infections 2. Does IVIG has potential immunomodulatory effect on transplanted organs
Epistemonikos ID: 47f39e7514a829ccab41054ce7b210835cb3ea21
First added on: Feb 19, 2024